Kathryn Moore Email

Human Resources Director . Virogin Biotech

Current Roles

Employees:
66
Revenue:
$10.2M
About
Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need. Our platform technology focuses on creating long-lasting antitumor immunity by capitalizing on a robust, transient antiviral immune response through a synergy with multiple payload expression. Virogin is designing a more potent oncolytic virus, expressing optimized payloads to enhance the systemic antitumor immunity in relapsed/refractory cancers. Led by our leadership team with over 25 years of experience in fundamental research, translational and clinical development of immunotherapy & oncolytic virotherapy, we are determined to bring our novel therapies for relapsed/refractory cancers to market.
Virogin Biotech Address
150-13511 Commerce Pkwy
Richmond, null
Canada
Virogin Biotech Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.